4//SEC Filing
Almstead Neil Gregory 4
Accession 0001578850-25-000006
CIK 0001070081other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:20 PM ET
Size
32.3 KB
Accession
0001578850-25-000006
Insider Transaction Report
Form 4
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-24$18.01/sh+1,900$34,219→ 102,525 total - Sale
Common Stock
2025-11-24$80.14/sh−1,900$152,266→ 100,625 total - Exercise/Conversion
Common Stock
2025-11-24$33.02/sh+1,650$54,483→ 102,275 total - Sale
Common Stock
2025-11-24$80.14/sh−1,650$132,231→ 100,625 total - Exercise/Conversion
Common Stock
2025-11-24$18.01/sh+4,715$84,917→ 105,340 total - Sale
Common Stock
2025-11-24$80.15/sh−4,715$377,907→ 100,625 total - Exercise/Conversion
Common Stock
2025-11-24$33.02/sh+21,206$700,222→ 121,831 total - Sale
Common Stock
2025-11-24$80.19/sh−21,206$1,700,509→ 100,625 total - Exercise/Conversion
Common Stock
2025-11-24$33.02/sh+6,101$201,455→ 106,726 total - Sale
Common Stock
2025-11-24$80.17/sh−6,101$489,117→ 100,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−1,900→ 15,600 totalExercise: $18.01Exp: 2028-01-02→ Common Stock (1,900 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−1,650→ 70,850 totalExercise: $33.02Exp: 2029-01-21→ Common Stock (1,650 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−4,715→ 10,885 totalExercise: $18.01Exp: 2028-01-02→ Common Stock (4,715 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−21,206→ 49,644 totalExercise: $33.02Exp: 2029-01-21→ Common Stock (21,206 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−6,101→ 11,399 totalExercise: $33.02Exp: 2029-01-21→ Common Stock (6,101 underlying)
Holdings
- 6,179(indirect: By Spouse)
Common Stock
Footnotes (7)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024.
- [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.14 to $80.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.56 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]Currently exercisable.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001578850
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 5:20 PM ET
- Size
- 32.3 KB